In TCGA’s analysis, these four subtypes did not show clear differences in overall survival but did underline the centrality of MAPK-pathway deregulation in melanoma—in fact, >90% of the BRAF, RAS, and NF1 subtypes showed UV-signature mutational spectra. Here, BRAF is linked to melanoma.